Blog

20 Apr 2018

Analysis Why prosecuting Indian pharma patents could be even more difficult than it appears

A study released this month sheds new light on the Indian Patent Office’s (IPO’s) application of Section 3(d) of the country’s Patents Act – a controversial section intended to circumscribe the issue of ‘secondary’ rights for pharmaceuticals products. It finds not only that Section 3(d) objections by the patent office have increased markedly over time, but that the provision has been widely invoked against ‘primary’ patent applications to protect Read more

Adam Houldsworth

20 Apr 2018

News Chinese companies expanding overseas face plenty of IP risk, but it need not overwhelm them

Here at IAM’s first IPBC Shenzhen event, Chinese companies with global ambitions were given a road map for how to develop their IP strategies as rapidly as their commercial ones. One overarching message local firms heard from both global tech giants and Chinese success stories was while IP problems are bound to arise, they might not be as overwhelming as they seem. For many relatively young firms here in the greater Shenzhen area – China’s Silicon Valley – the IP Read more

Jacob Schindler

19 Apr 2018

Analysis Senators push PTO Director Iancu for more 101 guidance and PTAB reform

During his first oversight hearing before the Senate Judiciary Committee yesterday, USPTO Director Andrei Iancu came under growing pressure to issue guidance on how recent changes in jurisprudence on patent eligible subject matter should be applied. Senator Kamala Harris, a recent appointee to the committee, quizzed Iancu on the uncertainty around section 101, particularly as it relates to artificial intelligence. This is an area of growing interest to the tech giants of her home state of Read more

Richard Lloyd

19 Apr 2018

News Women have worse outcomes in virtually all respects when it comes to securing US patent rights, study finds

Not only do women inventors submit far fewer US patent applications than men, but they also have much greater difficulty in obtaining and maintaining rights, a new study has revealed. The first-of-its-kind research found that female applicants are more likely to have their applications rejected and less likely to appeal these rejections. Women also had fewer claims allowed on average, while their granted patents received fewer citations and were less likely to be maintained. Published Read more

Timothy Au

19 Apr 2018

News Cost remains top priority and concern for most patent owners in Taiwan

Managing limited budget resources remains concern number one for most corporate patent owners in Taiwan – with just a handful of exceptions proving the rule. That was the biggest takeaway on Tuesday as over 200 senior executives from the private and public sectors came together at IPBC Taiwan in Taipei. Acer provides one typical example. Founded 40 year ago, the company is now transitioning beyond the hardware business, and moving into gaming and AI related products. Senior director Read more

Bing Zhao

18 Apr 2018

News IPBC programme and speaker line-up finalised; remaining delegate places limited

The full programme and speaking faculty for IPBC Global 2018, being held at the Palace Hotel in San Francisco from 10th to 12th of June, have now been finalised. More than 70 IP thought leaders from business, policy, finance and the legal sector are confirmed as speakers at the conference, which is acknowledged as the world’s foremost event about the business of intellectual property. Highlights for 2018 include … A wide range of topical, interactive, Read more

Joff Wild

17 Apr 2018

Analysis Supreme Court predicted to rule in favour of patent owners over damages abroad in case that could have major ramifications

For many observers of US patent law the current Supreme Court term essentially boils down to one case. But as we wait for the ruling in Oil States on the constitutionality of inter partes review, the justices had another case to hear yesterday on the extraterritoriality of damages law.  In Western Geco v Ion Geophysical Corp, the patent owner Western Geco, sued Ion in district court over components that Ion manufactured in the US but then shipped abroad for assembly. The resulting Read more

Richard Lloyd

17 Apr 2018

Analysis New Korean NPE seeks biometric security royalties from Samsung, Apple

There is a story going around in the Korean, Chinese and English-speaking media suggesting that Samsung Electronics faces a $2.8 billion patent infringement claim related to biometric technologies from US company PACid. This looks like a possible case of media mis-reporting. More interestingly, Samsung is facing down another challenge also based on its touch-to-unlock feature, this one from what looks like a new Korean NPE. First, in a case that has generated headlines for what is allegedly Read more

Jacob Schindler

16 Apr 2018

Analysis Troubled Korean smartphone maker supplies Apple with more US rights

Apple has acquired a portfolio of 27 US patents from Korean smartphone maker Pantech, according to assignment records filed with the USPTO. The transfer follows the iPhone manufacturer’s purchase last summer of a package of 11 patents from Korean NPE Goldpeak — assets which were originally owned by Pantech.   The latest portfolio appears to be largely focused on wireless technology and all of the grants have been made since 2012. Pantech is a Korean smartphone Read more

Richard Lloyd

16 Apr 2018

Analysis Latest Humira biosimilar settlement provides further proof of AbbVie patent strategy’s effectiveness

With the recent announcement that it had reached a settlement in its patent dispute with Samsung Bioepis, AbbVie has scored another significant victory in efforts to delay market entry to biosimilar versions of its drug, Humira. While allowing Samsung to launch its product in European jurisdictions later this year, the deal keeps the copycat arthritis treatment out of the lucrative US market until 2023. Following a similar agreement with Amgen – which has also developed a biosimilar Read more

Adam Houldsworth

Close

Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 89